NexgenRx, Inc.

  • Market Cap: Micro Cap
  • Industry: Miscellaneous
  • ISIN: CA65337X1042
CAD
0.34
-0.02 (-5.56%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
SSC Security Services Corp.
BQE Water, Inc.
NexgenRx, Inc.
Redishred Capital Corp.
Neptune Digital Assets Corp.
American Aires, Inc.
EverGen Infrastructure Corp.
Vertex Resource Group Ltd.
TDG Gold Corp.
Personas Social, Inc.
Base Carbon, Inc.

Why is NexgenRx, Inc. ?

1
High Management Efficiency with a high ROE of 17.21%
2
Company has a low Debt to Equity ratio (avg) at times
3
With a growth in Net Profit of 295.22%, the company declared Very Positive results in Sep 25
  • The company has declared positive results for the last 4 consecutive quarters
  • ROCE(HY) Highest at 17.61%
  • DEBT-EQUITY RATIO (HY) Lowest at -387.75 %
  • DIVIDEND PAYOUT RATIO(Y) Highest at 64.1%
4
With ROE of 17.41%, it has a expensive valuation with a 3.09 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 36.00%, its profits have risen by 119% ; the PEG ratio of the company is 0
5
Market Beating Performance
  • The stock has generated a return of 36.00% in the last 1 year, much higher than market (S&P/TSX 60) returns of 21.87%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to NexgenRx, Inc. should be less than 10%
  2. Overall Portfolio exposure to Miscellaneous should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is NexgenRx, Inc. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
NexgenRx, Inc.
36.0%
0.30
56.57%
S&P/TSX 60
21.87%
1.42
15.41%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
10.70%
EBIT Growth (5y)
-0.20%
EBIT to Interest (avg)
0.73
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-3.16
Sales to Capital Employed (avg)
1.82
Tax Ratio
37.71%
Dividend Payout Ratio
169.49%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
17.21%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
3.09
EV to EBIT
-6.93
EV to EBITDA
-3.19
EV to Capital Employed
0.29
EV to Sales
-0.42
PEG Ratio
0.04
Dividend Yield
NA
ROCE (Latest)
-3.74%
ROE (Latest)
17.41%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

26What is working for the Company
ROCE(HY)

Highest at 17.61%

DEBT-EQUITY RATIO (HY)

Lowest at -387.75 %

DIVIDEND PAYOUT RATIO(Y)

Highest at 64.1%

RAW MATERIAL COST(Y)

Fallen by -7.65% (YoY

CASH AND EQV(HY)

Highest at CAD 61.57 MM

PRE-TAX PROFIT(Q)

Highest at CAD 0.57 MM

NET PROFIT(Q)

Highest at CAD 0.59 MM

EPS(Q)

Highest at CAD 0.01

-3What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CAD -7.08 MM

Here's what is working for NexgenRx, Inc.

Pre-Tax Profit
At CAD 0.57 MM has Grown at 348.61%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CAD MM)

Net Profit
At CAD 0.59 MM has Grown at 295.22%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (CAD MM)

Debt-Equity Ratio
Lowest at -387.75 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Pre-Tax Profit
Highest at CAD 0.57 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CAD MM)

Net Profit
Highest at CAD 0.59 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CAD MM)

EPS
Highest at CAD 0.01
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (CAD)

Cash and Eqv
Highest at CAD 61.57 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Dividend Payout Ratio
Highest at 64.1%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost
Fallen by -7.65% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for NexgenRx, Inc.

Operating Cash Flow
Lowest at CAD -7.08 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CAD MM)